Using Astrocyte Factors to Prevent Synaptic Alterations in Alzheimer’s Disease
Principal Investigator
Isabel Salas, PhD
The Salk Institute for Biological Studies
La Jolla, CA, USA
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
September 01, 2020 - August 31, 2023
Grant ID
A20201645F
Mentor(s)
Nicola Allen, PhD, The Salk Institute for Biological Studies
Goals
The brain is the center of command of our bodies, controlling our motion, our behavior and our feelings. Its main components, the neurons, process information by making specialized connections (synapses) between them assisted by other important types of cells: the astrocytes. Alzheimer’s disease is associated with alterations in these connections. In this project I aim to restore the correct function of astrocytes, to rescue synaptic defects, in mouse models affected by Alzheimer disease and make a step further to the cure of this devastating disorder.
Summary
The brain is the center of command of our bodies. It controls our motion, our behavior, our feelings, our memories. Its main components, the neurons, process information by making fast connections, synapses, with each other. They are assisted by another important set of cells: the astrocytes. Astrocytes are cells with a star-shape that can contact more than one thousand different synapses. Their presence at the synapse is essential for correct transmission of information. In Alzheimer’s disease these synapses are lost, but we still do not fully understand why and how. In this project, I will study if changes to astrocytes in Alzheimer’s disease are responsible for the loss of synapses. To study this, I am using mice that have mutations in genes associated with Alzheimer’s disease, and that develop symptoms of the disease. Using these mice, I found that in Alzheimer’s disease astrocytes produce more levels of a factor, Glypican 5, important for synaptic function. I will test if this increase in Glypican 5 is toxic for synapses and is contributing to their loss in Alzheimer’s disease. I will do this by decreasing the levels of Glypican 5 in astrocytes from mice affected by Alzheimer’s disease. I expect that this reduction will restore the correct function of the synapses. These discoveries may have important implications for Alzheimer’s disease, by identifying a new way to prevent synapse loss and take a step further to the cure of this devastating disease.
Related Grants
Alzheimer's Disease Research
Monitoring Neural Activity and Neuroinflammation in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Feng Tian, PhD
Current Organization
Beth Israel Deaconess Medical Center
Monitoring Neural Activity and Neuroinflammation in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Feng Tian, PhD
Current Organization
Beth Israel Deaconess Medical Center
Alzheimer's Disease Research
Using Ultrasound to Help the Brain’s Defenses in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Nader Saffari, PhD
Current Organization
University College London
Using Ultrasound to Help the Brain’s Defenses in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Nader Saffari, PhD
Current Organization
University College London
Alzheimer's Disease Research
Understanding the Role of a Suppressed Immune System in Frontotemporal Dementia
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Rebecca Wallings, DPhil
Current Organization
Indiana University
Understanding the Role of a Suppressed Immune System in Frontotemporal Dementia
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Rebecca Wallings, DPhil
Current Organization
Indiana University